Organisational Structure of Boston Scientific : The Boston Scientific Corporation (NYSE: BSX) (abbreviated BSC), is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties, including interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

Boston Scientific is well known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. This product was at the center of a claim of patent infringement on the part of Boston Scientific, which was found liable for $431 million in damages.[1]

Boston Scientific's main competitors are Johnson & Johnson, Medtronic, and St. Jude Medical. The company recently acquired longtime competitor Guidant for approximately $27 billion. The former Guidant was split between BSC and Abbott Laboratories. [2] [3]

Navilyst Medical was formed in February 2008 from Boston Scientific's Fluid Management and Vascular Access business units. [4]

Beginning in 2003, Johnson & Johnson and Boston Scientific have been involved in a series of litigation involving patents covering heart stent medical devices. Both parties claimed that the other had infringed upon their patents. The litigation was settled once Boston Scientific agreed to pay $716 million to J&J in September 2009 and an additional $1.73 billion in February 2010.[5]

CEO
Ray Elliott
2
Chairman of the Board
Peter Nicholas
Director
Ray Groves
3
Director
Marye Fox
4
Director
Ernest Mario
2
Director
Uwe Reinhardt
3
Director
N. Nicholas
2
Director
Kristina Johnson
5
Director
Bruce Byrnes
4
Director
John Sununu
Director
Katharine Bartlett
Director
Nelda Connors
Director
John Abele
CFO
Jeffrey Capello
2
COO
Sam Leno
Technology
FC
Cardiology, Rhythm & Vascula...
WK
Administration & Legal
TP
Operations
KP
5
Strategy & Business Developm...
James Gilbert
Endoscopy
MP
2
Urology & Women's Health
John Pedersen
5
Communication
Paul Donovan
Human Resources
AM
Quality
BB
Compliance
JL
EMEA
FH
Japan
MN
International
DM
Neurovascular
MP
2
Endovascular Unit
Joseph Fitzgerald
Neuromodulation
MO
Sales Operations
SM


Taking the point of view of a manager, the literature that has been reviewed was sufficient in demonstrating the actual conduct of managers. The authors have comprehensively provided for research and ample studies in order to prove their theories. However, the only problem is that although the presentation of data were all comprehensive because of researches conducted and surveys, the fact that the conclusion still dwells down to theories without any actual application in order to guide the managers with their conduct.

In order to further explain, an example is necessary. An example is the theory of BizManualz stating that managers were not needed if the employees hired were competent enough without the guidance needed. The theory may seem to be applicable in the actual world. However, in order to show the accurateness of the said theory, it must be applied or tried by a certain organization in order to prove that is indeed workable and effective.

The managers will accept the appreciation of the theories presented by the different authorities if it has been applied and another report will be able to show its effectiveness. If the managers will try to adapt the theories with their responsibilities then if will be a trial and error.

Nevertheless, though this statement may seem to be in contrast to the above-mentioned statement. The success of the applicability of the theories will depend on how the company or organization will be able to conduct based on the theories. If the organization has reservation or by nature may not work with the theories, the trial will just remain to be a failure.

Hence, there are no major shortcomings but only a minor problem. Such minor problem can be easily treated and solved. As the shortcoming fell only to the actual applicability of the theories, the organizations’ company may simply try it on their company or conduct another feasibility study that can provide an assurance as to the efficiency of the said theories. As theories may remain to be called as theories because the applicability will always depend on the nature and characteristics of the subject that may have used or applied it on the real sense.
 
Last edited by a moderator:

jamescord

MP Guru
The Boston Scientific Corporation (NYSE: BSX) (abbreviated BSC), is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties, including interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

Boston Scientific is well known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. This product was at the center of a claim of patent infringement on the part of Boston Scientific, which was found liable for $431 million in damages.[1]

Boston Scientific's main competitors are Johnson & Johnson, Medtronic, and St. Jude Medical. The company recently acquired longtime competitor Guidant for approximately $27 billion. The former Guidant was split between BSC and Abbott Laboratories. [2] [3]

Navilyst Medical was formed in February 2008 from Boston Scientific's Fluid Management and Vascular Access business units. [4]

Beginning in 2003, Johnson & Johnson and Boston Scientific have been involved in a series of litigation involving patents covering heart stent medical devices. Both parties claimed that the other had infringed upon their patents. The litigation was settled once Boston Scientific agreed to pay $716 million to J&J in September 2009 and an additional $1.73 billion in February 2010.[5]

CEO
Ray Elliott
2
Chairman of the Board
Peter Nicholas
Director
Ray Groves
3
Director
Marye Fox
4
Director
Ernest Mario
2
Director
Uwe Reinhardt
3
Director
N. Nicholas
2
Director
Kristina Johnson
5
Director
Bruce Byrnes
4
Director
John Sununu
Director
Katharine Bartlett
Director
Nelda Connors
Director
John Abele
CFO
Jeffrey Capello
2
COO
Sam Leno
Technology
FC
Cardiology, Rhythm & Vascula...
WK
Administration & Legal
TP
Operations
KP
5
Strategy & Business Developm...
James Gilbert
Endoscopy
MP
2
Urology & Women's Health
John Pedersen
5
Communication
Paul Donovan
Human Resources
AM
Quality
BB
Compliance
JL
EMEA
FH
Japan
MN
International
DM
Neurovascular
MP
2
Endovascular Unit
Joseph Fitzgerald
Neuromodulation
MO
Sales Operations
SM


Taking the point of view of a manager, the literature that has been reviewed was sufficient in demonstrating the actual conduct of managers. The authors have comprehensively provided for research and ample studies in order to prove their theories. However, the only problem is that although the presentation of data were all comprehensive because of researches conducted and surveys, the fact that the conclusion still dwells down to theories without any actual application in order to guide the managers with their conduct.

In order to further explain, an example is necessary. An example is the theory of BizManualz stating that managers were not needed if the employees hired were competent enough without the guidance needed. The theory may seem to be applicable in the actual world. However, in order to show the accurateness of the said theory, it must be applied or tried by a certain organization in order to prove that is indeed workable and effective.

The managers will accept the appreciation of the theories presented by the different authorities if it has been applied and another report will be able to show its effectiveness. If the managers will try to adapt the theories with their responsibilities then if will be a trial and error.

Nevertheless, though this statement may seem to be in contrast to the above-mentioned statement. The success of the applicability of the theories will depend on how the company or organization will be able to conduct based on the theories. If the organization has reservation or by nature may not work with the theories, the trial will just remain to be a failure.

Hence, there are no major shortcomings but only a minor problem. Such minor problem can be easily treated and solved. As the shortcoming fell only to the actual applicability of the theories, the organizations’ company may simply try it on their company or conduct another feasibility study that can provide an assurance as to the efficiency of the said theories. As theories may remain to be called as theories because the applicability will always depend on the nature and characteristics of the subject that may have used or applied it on the real sense.
Hello friend,

Here i am uploading Organisational Chart of Boston Scientific Corporation, so please download and check it.
 

Attachments

Top